Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash flows from operating activities:
Net loss	$ (703,442)	$ (1,428,454)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	19,582	20,489
Realized gain on marketable securities		(26,375)
Unrealized gain on marketable securities		(30,399)
ROU asset amortization	107,229	109,051
Credit loss expense	25,001	95,000
Change in assets and liabilities:
Royalty receivables	(69,605)	(226,645)
Prepaid expenses and other assets	(57,943)	(63,612)
Accounts payable and accrued expenses	1,033	(52,784)
Deferred revenue		3,735
Operating lease liability	(157,754)	(146,323)
Net cash used in operating activities	(835,899)	(1,746,317)
Cash flows from investing activities:
Purchases of fixed assets	(742)	(1,265)
Purchases of marketable securities		(5,434,386)
Sales of marketable securities		2,991,535
Net cash used in investing activities	(742)	(2,444,116)
Cash flows from financing activities:
Net proceeds from exercise of options and warrants	8,670	484,502
Net cash provided by financing activities	8,670	484,502
Net decrease in cash and cash equivalents	(827,971)	(3,705,931)
Cash and cash equivalents at beginning of period	2,475,958	4,230,916
Cash and cash equivalents at end of period	$ 1,647,987	$ 524,985